Go to: content | top | bottom | search
EN    FR  
You are hereUNIL > Institute of Biotechnolgy > Research > Publications > Publications of all members

Publications of all IBT members

2016 |  2015 |  2014 |  2013 |  2012 |  2011 |  2010 |  2009 |  2008 |  2007 |  2006 |  2005 |  2004 |  2003 |  2002 |  2001 |  2000 |  1999 |  1998 |  1997 |  1996 |  Thèses (doctorat) | 

Bire S., Casteret S., Piégu B., Beauclair L., Moiré N., Arensbuger P., Bigot Y., 2016. Mariner Transposons Contain a Silencer: Possible Role of the Polycomb Repressive Complex 2. PLoS Genetics 12(3) pp. e1005902. [Document] [DOI] [Web of Science] [Pubmed]
Kostyrko K., Mermod N., 2016. Assays for DNA double-strand break repair by microhomology-based end-joining repair mechanisms. Nucleic Acids Research 44(6) pp. e56. [Document] [DOI] [Pubmed]
Edelmann S., Fahrner R., Malinka T., Song B.H., Stroka D., Mermod N., 2015. Nuclear Factor I-C acts as a regulator of hepatocyte proliferation at the onset of liver regeneration. Liver International 35(4) pp. 1185-1194. [DOI] [Web of Science] [Pubmed]
Harraghy N., Calabrese D., Fisch I., Girod P.A., LeFourn V., Regamey A., Mermod N., 2015. Epigenetic regulatory elements: Recent advances in understanding their mode of action and use for recombinant protein production in mammalian cells. Biotechnology Journal 10(7) pp. 967-978. [DOI] [Web of Science] [Pubmed]
Kostyrko K., Bosshard S., Urban Z., Mermod N., 2015. A role for homologous recombination proteins in cell cycle regulation. Cell Cycle 14(17) pp. 2853-2861. [DOI] [Web of Science] [Pubmed]
Piégu B., Bire S., Arensburger P., Bigot Y., 2015. A survey of transposable element classification systems--a call for a fundamental update to meet the challenge of their diversity and complexity. Molecular Phylogenetics and Evolution 86 pp. 90-109. [Document] [DOI] [Web of Science] [Pubmed]
Alberti L., Renaud S., Losi L., Leyvraz S., Benhattar J., 2014. High Expression of hTERT and Stemness Genes in BORIS/CTCFL Positive Cells Isolated from Embryonic Cancer Cells. PLoS One 9(10) pp. e109921. [Document] [DOI] [Web of Science] [Pubmed]
Deák F., Mátés L., Korpos E., Zvara A., Szénási T., Kiricsi M., Mendler L., Keller-Pintér A., Ozsvári B., Juhász H. et al., 2014. Extracellular deposition of matrilin-2 controls the timing of the myogenic program during muscle regeneration. Journal of Cell Science 127(Pt 15) pp. 3240-3256. [DOI] [Web of Science] [Pubmed]
Le Fourn V., Girod P.A., Buceta M., Regamey A., Mermod N., 2014. CHO cell engineering to prevent polypeptide aggregation and improve therapeutic protein secretion. Metabolic Engineering 21 pp. 91-102. [DOI] [Web of Science] [Pubmed]
Ley D., Van Zwieten R., Puttini S., Iyer P., Cochard A., Mermod N., 2014. A PiggyBac-mediated approach for muscle gene transfer or cell therapy. Stem Cell Research 13(3 Pt A) pp. 390-403. [DOI] [Web of Science] [Pubmed]
Majocchi S., Aritonovska E., Mermod N., 2014. Epigenetic regulatory elements associate with specific histone modifications to prevent silencing of telomeric genes. Nucleic Acids Research 42(1) pp. 193-204. [Document] [DOI] [Web of Science] [Pubmed]
Puttini S., Panaite P.A., Mermod N., Renaud S., Steck A.J., Kuntzer T., 2014. Gene expression changes in chronic inflammatory demyelinating polyneuropathy skin biopsies. Journal of Neuroimmunology 270(1-2) pp. 61-66. [DOI] [Web of Science] [Pubmed]
Arope S., Harraghy N., Pjanic M., Mermod N., 2013. Molecular characterization of a human matrix attachment region epigenetic regulator. PLoS One 8(11) pp. e79262. [Document] [DOI] [Web of Science] [Pubmed]
Bire S., Casteret S., Arnaoty A., Piégu B., Lecomte T., Bigot Y., 2013. Transposase concentration controls transposition activity: myth or reality? Gene 530(2) pp. 165-171. [DOI] [Web of Science] [Pubmed]
Bire S., Gosset D., Jégot G., Midoux P., Pichon C., Rouleux-Bonnin F., 2013. Exogenous mRNA delivery and bioavailability in gene transfer mediated by piggyBac transposition. BMC Biotechnology 13 p. 75. [DOI] [Web of Science] [Pubmed]
Bire S., Ley D., Casteret S., Mermod N., Bigot Y., Rouleux-Bonnin F., 2013. Optimization of the piggyBac Transposon Using mRNA and Insulators: Toward a More Reliable Gene Delivery System. PLoS One 8(12) pp. e82559. [Document] [DOI] [Web of Science] [Pubmed]
Contie M., Leger O., Fouque N., Poitevin Y., Kosco-Vilbois M., Mermod N., Elson G., 2013. IL-17F co-expression improves cell growth characteristics and enhances recombinant protein production during CHO cell line engineering. Biotechnology and Bioengineering 110(4) pp. 1153-1163. [DOI] [Web of Science] [Pubmed]
Ley D., Harraghy N., Le Fourn V., Bire S., Girod P.A., Regamey A., Rouleux-Bonnin F., Bigot Y., Mermod N., 2013. MAR elements and transposons for improved transgene integration and expression. PLoS One 8(4) pp. e62784. [Document] [DOI] [Web of Science] [Pubmed]
Pjanic M., Schmid C.D., Gaussin A., Ambrosini G., Adamcik J., Pjanic P., Plasari G., Kerschgens J., Dietler G., Bucher P. et al., 2013. Nuclear Factor I genomic binding associates with chromatin boundaries. BMC Genomics 14 p. 99. [Document] [DOI] [Web of Science] [Pubmed]
Puttini S., van Zwieten R.W., Saugy D., Lekka M., Hogger F., Ley D., Kulik A.J., Mermod N., 2013. MAR-mediated integration of plasmid vectors for in vivo gene transfer and regulation. BMC Molecular Biology 14 p. 26. [Document] [DOI] [Web of Science] [Pubmed]
Brunner J.M., Plattet P., Doucey M.A., Rosso L., Curie T., Montagner A., Wittek R., Vandelvelde M., Zurbriggen A., Hirling H. et al., 2012. Morbillivirus glycoprotein expression induces ER stress, alters Ca2+ homeostasis and results in the release of vasostatin. PLoS One 7(3) pp. e32803. [Document] [DOI] [Web of Science] [Pubmed]
Gaussin A., Modlich U., Bauche C., Niederländer N.J., Schambach A., Duros C., Artus A., Baum C., Cohen-Haguenauer O., Mermod N., 2012. CTF/NF1 transcription factors act as potent genetic insulators for integrating gene transfer vectors. Gene Therapy 19(1) pp. 15-24. [DOI] [Web of Science] [Pubmed]
Harraghy N., Buceta M., Regamey A., Girod P.A., Mermod N., 2012. Using matrix attachment regions to improve recombinant protein production. Methods in Molecular Biology 801 pp. 93-110. [DOI] [Web of Science] [Pubmed]
Mernier G., Majocchi S., Mermod N., Renaud P., 2012. In situ evaluation of single-cell lysis by cytosol extraction observation through fluorescence decay and dielectrophoretic trapping time. Sensors and Actuators B-Chemical 166 pp. 907-912. [DOI] [Web of Science]
Buceta M., Galbete J.L., Kostic C., Arsenijevic Y., Mermod N., 2011. Use of human MAR elements to improve retroviral vector production. Gene Therapy 18(1) pp. 7-13. [DOI] [Web of Science] [Pubmed]
Harraghy N., Regamey A., Girod P.A., Mermod N., 2011. Identification of a potent MAR element from the mouse genome and assessment of its activity in stable and transient transfections. Journal of Biotechnology 154(1) pp. 11-20. [DOI] [Web of Science] [Pubmed]
Kerschgens J., Renaud S., Schütz F., Grasso L., Egener-Kuhn T., Delaloye J.F., Lehr H.A., Vogel H., Mermod N., 2011. Protein-Binding Microarray Analysis of Tumor Suppressor AP2α Target Gene Specificity. Plos One 6(8) pp. e22895. [Document] [DOI] [Web of Science] [Pubmed]
Pjanic M., Pjanic P., Schmid C., Ambrosini G., Gaussin A., Plasari G., Mazza C., Bucher P., Mermod N., 2011. Nuclear factor I revealed as family of promoter binding transcription activators. BMC Genomics 12 p. 181. [Document] [DOI] [Web of Science] [Pubmed]
Renaud S., Loukinov D., Alberti L., Vostrov A., Kwon Y.W., Bosman F.T., Lobanenkov V., Benhattar J., 2011. BORIS/CTCFL-mediated transcriptional regulation of the hTERT telomerase gene in testicular and ovarian tumor cells. Nucleic Acids Research 39(3) pp. 862-873. [Document] [DOI] [Web of Science] [Pubmed]
Plasari G., Edelmann S., Högger F., Dusserre Y., Mermod N., Calabrese A., 2010. Nuclear factor I-C regulates TGF-{beta}-dependent hair follicle cycling. Journal of Biological Chemistry 285(44) pp. 34115-34125. [DOI] [Web of Science] [Pubmed]
Artus A., Duros C., Botbol Y., Gaussin A., Mermod N., Lavigne M., Cohen-Haguenauer O., 2009. Directed integration of new insulated lentiviral vectors to heterochromatin towards safer gene transfer to stem cells. pp. 1502-1502 in ESGCT, DGGT, GSZ, and ISCT 2009 Poster Presentations. Human Gene Therapy 20(11). [DOI] [Web of Science]
Bertseva E., Singh A.S., Lekki J., Thévenaz P., Lekka M., Jeney S., Gremaud G., Puttini S., Nowak W., Dietler G. et al., 2009. Intracellular nanomanipulation by a photonic-force microscope with real-time acquisition of a 3D stiffness matrix. Nanotechnology 20(28) p. 285709. [DOI] [Web of Science] [Pubmed]
Colland F., Formstecher E., Jacq X., Reverdy C., Planquette C., Conrath S., Trouplin V., Bianchi J., Aushev V.N., Camonis J. et al., 2009. Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells. Molecular Cancer Therapeutics 8(8) pp. 2286-2295. [DOI] [Web of Science] [Pubmed]
Duros C., Artus A., Auclair C., Gaussin A., Mermod N., Arock M., Schmidt M., Von Kalle C., Cohen-Haguenauer O. Y., 2009. Insulated retroviral vectors towards safe and efficient genetic modification of stem cells. pp. 666-666 in SFTCG 2009 Oral Presentations. Human Gene Therapy 20(6). [DOI] [Web of Science]
Duros C., Artus A., Gaussin A., Scholtz S., Mermod N., Schmidt M., von Kalle C., Cohen-Haguenauer O., 2009. Novel insulated gamma and lentis retroviral vectors towards safer genetic modification of stem cells. pp. 1505-1505 in ESGCT, DGGT, GSZ, and ISCT 2009 Poster Presentations. Human Gene Therapy 20(11). [DOI] [Web of Science]
Escher P., Gouras P., Roduit R., Tiab L., Bolay S., Delarive T., Chen S., Tsai C.C., Hayashi M., Zernant J. et al., 2009. Mutations in NR2E3 can cause dominant or recessive retinal degenerations in the same family. Human Mutation 30(3) pp. 342-351. [Document] [DOI] [Web of Science] [Pubmed]
Esnault G., Majocchi S., Martinet D., Besuchet-Schmutz N., Beckmann J.S., Mermod N., 2009. Transcription factor CTF1 acts as a chromatin domain boundary that shields human telomeric genes from silencing. Molecular and Cellular Biology 29(9) pp. 2409-2418. [DOI] [Web of Science] [Pubmed]
Fournier T., Gabriel J.P., Pasquier J., Mazza C., Galbete J., Mermod N., 2009. Stochastic models and numerical algorithms for a class of regulatory gene networks. Bulletin of Mathematical Biology 71(6) pp. 1394-1431. [DOI] [Web of Science] [Pubmed]
Galbete J.L., Buceta M., Mermod N., 2009. MAR elements regulate the probability of epigenetic switching between active and inactive gene expression. Molecular BioSystems 5(2) pp. 143-150. [DOI] [Web of Science] [Pubmed]
Gaussin A., Duros C., Artus A., Auclair C., Cohen-Haguenauer O., Mermod N., 2009. Avoiding epigenetic variations in transgene expression with genetic insulators. pp. 1506-1506 in ESGCT, DGGT, GSZ, and ISCT 2009 Poster Presentations. Human Gene Therapy 20(11). [DOI] [Web of Science]
Gaussin A., Mermod N., 2009. Chromatin insulators and Prospective Application for gene Therapy. Gene Therapy Review pp. on line. [url editor site]
Gorman C., Arope S., Grandjean M., Girod P.-A., Mermod N., 2009. Use of MAR elements to increase the production of recombinant proteins. pp. 1-32 in Al-Rubeai M. (eds.) Cell Line Development. Cell Engineering 6. Springer, Dordrecht. [url editor site] [DOI]
Kerschgens J., Egener-Kuhn T., Mermod N., 2009. Protein-binding microarrays: probing disease markers at the interface of proteomics and genomics. Trends in Molecular Medicine 15(8) pp. 352-358. [DOI] [Web of Science] [Pubmed]
Mermod N., 2009. Characterization of insulators and barrier elements for gene therapy. pp. 658-658 in SFTCG 2009 Invited Presentations. Human Gene Therapy 20(6). [DOI]
Plasari G., Calabrese A., Dusserre Y., Gronostajski R.M., McNair A., Michalik L., Mermod N., 2009. Nuclear factor I-C links platelet-derived growth factor and transforming growth factor beta1 signaling to skin wound healing progression. Molecular and Cellular Biology 29(22) pp. 6006-6017. [DOI] [Web of Science] [Pubmed]
Puttini S., Lekka M., Dorchies O.M., Saugy D., Incitti T., Ruegg U.T., Bozzoni I., Kulik A.J., Mermod N., 2009. Gene-mediated restoration of normal myofiber elasticity in dystrophic muscles. Molecular Therapy 17(1) pp. 19-25. [DOI] [Web of Science] [Pubmed]
Puttini S., Lekka M., Kuntzer T., Mermod N., Kulik A., 2009. Diagnosis of muscular dystrophies at the nanometer scale. pp. 544-545 in 14th International Congress of the World Muscle Society. Neuromuscular Disorders 19(8-9). [DOI] [Web of Science]
Ruijter J.M., Ramakers C., Hoogaars W.M., Karlen Y., Bakker O., van den Hoff M.J., Moorman A.F., 2009. Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Research 37(6) pp. e45. [DOI] [Web of Science] [Pubmed]
Buceta M., Domínguez E., Castro M., Brea J., Alvarez D., Barcala J., Valdés L., Alvarez-Calderón P., Domínguez F., Vidal B. et al., 2008. A new chemical tool (C0036E08) supports the role of adenosine A(2B) receptors in mediating human mast cell activation. Biochemical Pharmacology 76(7) pp. 912-921. [DOI] [Web of Science] [Pubmed]
Harraghy N., Gaussin A., Mermod N., 2008. Sustained transgene expression using MAR elements. Current Gene Therapy 8(5) pp. 353-366. [DOI] [Web of Science] [Pubmed]
Brunner J.M., Plattet P., Majcherczyk P., Zurbriggen A., Wittek R., Hirling H., 2007. Canine distemper virus infection of primary hippocampal cells induces increase in extracellular glutamate and neurodegeneration. Journal of Neurochemistry 103(3) pp. 1184-1195. [DOI] [Web of Science] [Pubmed]
Fournier T., Gabriel J.P., Mazza C., Pasquier J., Galbete J.L., Mermod N., 10-2007. Steady-state expression of self-regulated genes. Bioinformatics 23(23) pp. 3185-3192. [DOI] [Web of Science] [Pubmed]
Gaussin A., Esnault G., Mermod N., 2007. Genetic insulators and epigenetic variations in gene expression and regulation. pp. 989-989 in 15th Annual Congress of the European Society of Gene and Cell Therapy. Human Gene Therapy 18(10). [Web of Science]
Girod P.A., Nguyen D.Q., Calabrese D., Puttini S., Grandjean M., Martinet D., Regamey A., Saugy D., Beckmann J.S., Bucher P. et al., 09-2007. Genome-wide prediction of matrix attachment regions that increase gene expression in mammalian cells. Nature Methods 4(9) pp. 747-753. [DOI] [Web of Science] [Pubmed]
Harraghy N., Kerdudou S., Herrmann M., 2007. Quorum-sensing systems in staphylococci as therapeutic targets. Analytical and Bioanalytical Chemistry 387(2) pp. 437-444. [DOI] [Web of Science] [Pubmed]
Karlen Y., McNair A., Perseguers S., Mazza C., Mermod N., 2007. Statistical significance of quantitative PCR. Bmc Bioinformatics 8 p. 131. [Document] [DOI] [Web of Science] [Pubmed]
Plattet P., Cherpillod P., Wiener D., Zipperle L., Vandevelde M., Wittek R., Zurbriggen A., 10-2007. Signal peptide and helical bundle domains of virulent canine distemper virus fusion protein restrict fusogenicity. Journal of Virology 81(20) pp. 11413-11425. [DOI] [Web of Science] [Pubmed]
Girod P.A., Grandjean M., Calabrese D., Martinet D., Beckmann J., Mermod N., 2006. Fast generation of high producer cho cell lines by an iterative transfection process. pp. S41 in 4th Recombinant Protein Production Meeting. Microbial Cell Factories 5(Suppl. 1). [Document] [DOI]
Vyroubalova E.C., Hartley O., Mermod N., Fisch I., 04-2006. Identification of peptide ligands to the chemokine receptor CCR5 and their maturation by gene shuffling. Molecular Immunology 43(10) pp. 1573-1578. [DOI] [Web of Science] [Pubmed]
Wittek R., 05-2006. Vaccinia immune globulin: current policies, preparedness, and product safety and efficacy. International Journal of Infectious Diseases 10(3) pp. 193-201. [DOI] [Web of Science] [Pubmed]
Egener T., Roulet E., Zehnder M., Bucher P., Mermod N., 2005. Proof of concept for microarray-based detection of DNA-binding oncogenes in cell extracts. Nucleic Acids Research 33(8) pp. e79. [Document] [DOI] [Web of Science] [Pubmed]
Girod P.A., Zahn-Zabal M., Mermod N., 07-2005. Use of the chicken lysozyme 5' matrix attachment region to generate high producer CHO cell lines. Biotechnology and Bioengineering 91(1) pp. 1-11. [DOI] [Web of Science] [Pubmed]
Girod P.A., Zahn-Zabal M.M., Mermod N., 2005. MAR elements as tools to increase protein production by CHO cells. pp. 411-415 in Gòdia F., Fussenegger M. (eds.) Animal Cell Technology Meets Genomics. ESACT Proceedings 2. Springer, Dordrecht. [DOI]
Pankiewicz R., Karlen Y., Imhof M.O., Mermod N., 01-2005. Reversal of the silencing of tetracycline-controlled genes requires the coordinate action of distinctly acting transcription factors. Journal of Gene Medicine 7(1) pp. 117-132. [DOI] [Web of Science] [Pubmed]
Plattet P., Rivals J.P., Zuber B., Brunner J.M., Zurbriggen A., Wittek R., 07-2005. The fusion protein of wild-type canine distemper virus is a major determinant of persistent infection. Virology 337(2) pp. 312-326. [DOI] [Web of Science] [Pubmed]
Schween G., Egener T., Fritzowsky D., Granado J., Guitton M.C., Hartmann N., Hohe A., Holtorf H., Lang D., Lucht J.M. et al., 2005. Large-scale analysis of 73 329 physcomitrella plants transformed with different gene disruption libraries: production parameters and mutant phenotypes. Plant Biology 7(3) pp. 228-237. [DOI] [Web of Science] [Pubmed]
Suarez M., Haenni M., Canarelli S., Fisch F., Chodanowski P., Servis C., Michielin O., Freitag R., Moreillon P., Mermod N., 2005. Structure-function characterization and optimization of a plant-derived antibacterial peptide. Antimicrobial Agents and Chemotherapy 49(9) pp. 3847-3857. [DOI] [Web of Science] [Pubmed]
Cherpillod P., Zipperle L., Wittek R., Zurbriggen A., 10-2004. An mRNA region of the canine distemper virus fusion protein gene lacking AUG codons can promote protein expression. Archives of Virology 149(10) pp. 1971-1983. [DOI] [Web of Science] [Pubmed]
Ferrari S., Simmen K.C., Dusserre Y., Müller K., Fourel G., Gilson E., Mermod N., 12-2004. Chromatin domain boundaries delimited by a histone-binding protein in yeast. Journal of Biological Chemistry 279(53) pp. 55520-55530. [DOI] [Web of Science] [Pubmed]
Plattet P., Zweifel C., Wiederkehr C., Belloy L., Cherpillod P., Zurbriggen A., Wittek R., 05-2004. Recovery of a persistent Canine distemper virus expressing the enhanced green fluorescent protein from cloned cDNA. Virus Research 101(2) pp. 147-153. [DOI] [Web of Science] [Pubmed]
Tan N.S., Michalik L., Di-Poï N., Ng C.Y., Mermod N., Roberts A.B., Desvergne B., Wahli W., 2004. Essential role of Smad3 in the inhibition of inflammation-induced PPARbeta/delta expression. EMBO Journal 23(21) pp. 4211-4221. [DOI] [Web of Science] [Pubmed]
Wittek R., 10-2004. Could smallpox come back? International Journal of Infectious Diseases 8 Suppl 2 pp. S1. [DOI] [Web of Science] [Pubmed]
Briguet A., Bleckmann D., Bettan M., Mermod N., Meier T., 02-2003. Transcriptional activation of the utrophin promoter B by a constitutively active Ets-transcription factor. Neuromuscular Disorders 13(2) pp. 143-150. [DOI] [Web of Science] [Pubmed]
Girod P. A., Mermod N., 2003. Use of scaffold/matrix-attachment regions for protein production. pp. 359-379 in Makrides S.C. (eds.) Gene transfer and expression in mammalian cells. New Comprehensive Biochemistry 38. Elsevier, Amsterdam. [DOI]
Suarez M., Entenza J.M., Doerries C., Meyer E., Bourquin L., Sutherland J., Marison I., Moreillon P., Mermod N., 2003. Expression of a plant-derived peptide harboring water-cleaning and antimicrobial activities. Biotechnology and Bioengineering 81(1) pp. 13-20. [DOI] [Web of Science] [Pubmed]
Imhof M.O., Chatellard P., Mermod N., 2002. Comparative study and identification of potent eukaryotic transcriptional repressors in gene switch systems. Journal of Biotechnology 97(3) pp. 275-285. [DOI] [Web of Science] [Pubmed]
Mermod N., Cornetta K.G., 2002. Gene transfer : The ins, the outs... and the next generation. Current Opinion in Biotechnology 13(5) pp. 415-417. [DOI] [Web of Science]
Roulet E., Busso S., Camargo A.A., Simpson A.J., Mermod N., Bucher P., 2002. High-throughput SELEX SAGE method for quantitative modeling of transcription-factor binding sites. Nature Biotechnology 20(8) pp. 831-835. [DOI] [Web of Science] [Pubmed]
Cottet-Maire F., Avdonin P.V., Roulet E., Buetler T.M., Mermod N., Ruegg U.T., 02-2001. Upregulation of vasopressin V1A receptor mRNA and protein in vascular smooth muscle cells following cyclosporin A treatment. British Journal of Pharmacology 132(4) pp. 909-917. [DOI] [Web of Science] [Pubmed]
Fourel G., Boscheron C., Revardel E., Lebrun E., Hu Y.F., Simmen K.C., Müller K., Li R., Mermod N., Gilson E., 02-2001. An activation-independent role of transcription factors in insulator function. EMBO Reports 2(2) pp. 124-132. [DOI] [Web of Science] [Pubmed]
Zahn-Zabal M., Kobr M., Girod P.A., Imhof M., Chatellard P., de Jesus M., Wurm F., Mermod N., 04-2001. Development of stable cell lines for production or regulated expression using matrix attachment regions. Journal of Biotechnology 87(1) pp. 29-42. [DOI] [Web of Science] [Pubmed]
Imhof M.O., Chatellard P., Mermod N., 2000. A regulatory network for the efficient control of transgene expression. The Journal of Gene Medicine 2(2) pp. 107-116. [DOI] [Web of Science] [Pubmed]
Miescher S., Zahn-Zabal M., De Jesus M., Moudry R., Fisch I., Vogel M., Kobr M., Imboden M.A., Kragten E., Bichler J. et al., 2000. CHO expression of a novel human recombinant IgG1 anti-RhD antibody isolated by phage display. British Journal of Haematology 111(1) pp. 157-166. [DOI] [Web of Science] [Pubmed]
Müller K., Mermod N., 2000. The histone-interacting domain of nuclear factor I activates simian virus 40 DNA replication in vivo. Journal of Biological Chemistry 275(3) pp. 1645-1650. [DOI] [Web of Science] [Pubmed]
Roulet E., Bucher P., Schneider R., Wingender E., Dusserre Y., Werner T., Mermod N., 2000. Experimental analysis and computer prediction of CTF/NFI transcription factor DNA binding sites. Journal of Molecular Biology 297(4) pp. 833-848. [DOI] [Web of Science] [Pubmed]
Amstutz H., Miescher S., Moudry R., Desjardin S., Imboden M., Morgenthaler J.J., Zahn M., Kobr M., Fisch I., Corthésy B. et al., 1999. The SPP Biotech Module 1: Proteins for medical applications. A multidisciplinary effort for the development of a recombinant anti-RHD antibody preparation for the prevention of the hemolytic disease of the newborn. pp. 455-458 in Bernard A., Griffiths B., Noé W., Wurm F. (eds.) Animal cell technology: products from cells, cells as products. Kluwer Academic Publishing, Dordrecht.
Morel Y., Mermod N., Barouki R., 1999. An autoregulatory loop controlling CYP1A1 gene expression: role of H(2)O(2) and NFI. Molecular and Cellular Biology 19(10) pp. 6825-6832. [Web of Science] [Pubmed]
Von Stockar U., Kragten E., Marison I.W., Amstutz H., Miescher S., Fisch I., Mermod N., DeJesus M., Freitag R., Wurm F., 1999. Biotechnology in Lausanne: the Rh D project. Chimia 53(11) pp. 554-557. [Web of Science]
Zahn M., Kobr M., Mermod N, 1999. Matrix attachment regions in stable CHO cell line development. pp. 79-81 in Bernard A., Griffiths B., Noé W., Wurm F. (eds.) Animal cell technology: products from cells, cells as products. Kluwer, New York. [DOI]
Roulet E., Fisch I., Junier T., Bucher P., Mermod N., 1998. Evaluation of computer tools for the prediction of transcription factor binding sites on genomic DNA. In Silico Biology 1(1) pp. 21-28. [Pubmed]
Schwarz A., Rossier J.S., Roulet E., Mermod N., Roberts M.A., Girault H.H., 1998. Micro-patterning of biomolecules on polymer substrates. Langmuir 14(19) pp. 5526-5531. [DOI] [Web of Science]
Alevizopoulos A., Dusserre Y., Rüegg U., Mermod N., 1997. Regulation of the transforming growth factor beta-responsive transcription factor CTF-1 by calcineurin and calcium/calmodulin-dependent protein kinase IV. Journal of Biological Chemistry 272(38) pp. 23597-23605. [DOI] [Web of Science] [Pubmed]
Alevizopoulos A., Mermod N., 07-1997. Transforming growth factor-beta: the breaking open of a black box. Bioessays 19(7) pp. 581-591. [DOI] [Web of Science] [Pubmed]
Masternak K., Wittek R., 1996. cis- and trans-acting elements involved in reactivation of vaccinia virus early transcription. Journal of virology 70(12) pp. 8737-46. [Web of Science] [Pubmed]
Phd thesis
Esnault Germain, 2008. Analyse des modifications de la chromatine impliquées dans l'effet barrière de CTF1 aux télomères humains. 106 p., Université de Lausanne, Faculté de biologie et médecine, Mermod Nicolas (dir.). [Document]
Rivals J.-P., 2006. Cellular and viral factors implicated in persistent infection in canine distemper virus. 137 p., Université de Lausanne, Faculté de biologie et médecine, Wittek R. (dir.).
Ferrari S., 2005. Analysis of a boundary protein delimiting chromatin domains in yeast. 153 p., Université de Lausanne, Faculté de biologie et médecine, Mermod N. (dir.).
Suarez M., 2005. Characterization of a plant-derived peptide displaying water clarifying and antimicrobial activities. 122 p., Université de Lausanne, Faculté de biologie et médecine, Mermod N. (dir.).
Plattet P., 2004. Reverse genetics as a tool to study molecular determinants of cell culture-adaptation and persistence in wild-type canine distemper virus. 161 p., Université de Lausanne, Faculté de biologie et médecine, Wittek R. (dir.).
Schwenter F., 2004. A cell therapy approach for erythropoietin delivery using encapsulated human primary fibroblasts. 160 p., Université de Lausanne, Faculté de biologie et médecine, Aebischer P. (dir.).
Vyroubalová E., 2004. Isolation and characterization of peptide ligands: from protein-protein interactions to novel potential drug leads. 169 p., Université de Lausanne, Faculté de biologie et médecine, Fisch I. (dir.).
Zweifel C., 2004. Role of mutations in the phosphoprotein on RNA polymerase activity of canine distemper virus following cell culture adaptation. 125 p., Université de Lausanne, Faculté de biologie et médecine, Wittek R. (dir.). [Document]
EPFL FSB-LBTM, CH B1-391, Station 6, CH-1015 Lausanne  -  Tel. +41 21 693 76 16  -  Fax +41 21 693 76 10
Swiss University